Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
60.0%
% of BBH's 27 holdings also in XBI
11.0%
% of XBI's 136 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.5% | 2.7% | 2.7% |
|
NATERA INC | 2.9% | 2.6% | 2.6% |
|
GILEAD SCIENCES INC | 9.3% | 2.6% | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 10.3% | 2.5% | 2.5% |
|
AMGEN INC | 17.0% | 2.5% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to XBI
|
AMGEN INC | 14.5% |
|
VERTEX PHARMACEUTICALS INC | 7.7% |
|
GILEAD SCIENCES INC | 6.7% |
|
REGENERON PHARMACEUTICALS | 6.0% |
|
IQVIA HOLDINGS INC | 4.9% |
 |
ICON PLC | 4.6% |
 |
ARGENX SE ADR | 4.5% |
|
ILLUMINA INC | 4.1% |
 |
BIONTECH SE SPONSORED ADR | 2.5% |
|
BEIGENE LTD. SPONSORED ADR | 2.0% |
BBH Underweight Relative to XBI
|
UNITED THERAPEUTICS CORP | -2.7% |
|
ABBVIE INC | -2.5% |
|
VIKING THERAPEUTICS, INC. | -2.5% |
|
BLUEPRINT MEDICINES CORP. | -1.6% |
|
CRISPR THERAPEUTICS AG | -1.5% |
|
HALOZYME THERAPEUTICS INC | -1.5% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.4% |
|
AVIDITY BIOSCIENCES INC | -1.4% |
|
REVOLUTION MEDICINES, INC. | -1.3% |
|
INCYTE CORP | -1.3% |